Morishita Jintan Co., Ltd. (4524.T)

JPY 2065.0

(0.05%)

Operating Income Summary of Morishita Jintan Co., Ltd.

  • Morishita Jintan Co., Ltd.'s latest annual operating income in 2023 was 716 Million JPY , up 25.83% from previous year.
  • Morishita Jintan Co., Ltd.'s latest quarterly operating income in 2024 Q1 was 316 Million JPY , up 237.39% from previous quarter.
  • Morishita Jintan Co., Ltd. reported an annual operating income of 569 Million JPY in 2022, up 90.3% from previous year.
  • Morishita Jintan Co., Ltd. reported an annual operating income of 299 Million JPY in 2021, up 34.08% from previous year.
  • Morishita Jintan Co., Ltd. reported a quarterly operating income of 325 Million JPY for 2023 Q3, up 30.0% from previous quarter.
  • Morishita Jintan Co., Ltd. reported a quarterly operating income of 250 Million JPY for 2023 Q2, down -32.61% from previous quarter.

Annual Operating Income Chart of Morishita Jintan Co., Ltd. (2023 - 2019)

Historical Annual Operating Income of Morishita Jintan Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 716 Million JPY 25.83%
2022 569 Million JPY 90.3%
2021 299 Million JPY 34.08%
2020 223 Million JPY -50.88%
2019 454 Million JPY 0.0%

Peer Operating Income Comparison of Morishita Jintan Co., Ltd.

Name Operating Income Operating Income Difference
Pharma Foods International Co., Ltd. 5.11 Billion JPY 85.996%
Takeda Pharmaceutical Company Limited 214.07 Billion JPY 99.666%
Sumitomo Pharma Co., Ltd. -354.19 Billion JPY 100.202%
Shionogi & Co., Ltd. 171.46 Billion JPY 99.582%
Wakamoto Pharmaceutical Co.,Ltd. -195.51 Million JPY 466.22%
Nippon Shinyaku Co., Ltd. 31.38 Billion JPY 97.719%
Kaken Pharmaceutical Co., Ltd. 9.51 Billion JPY 92.473%
Eisai Co., Ltd. 53.4 Billion JPY 98.659%
Hisamitsu Pharmaceutical Co., Inc. 13.16 Billion JPY 94.562%
Mochida Pharmaceutical Co., Ltd. 5.8 Billion JPY 87.662%
Fuso Pharmaceutical Industries,Ltd. 1.96 Billion JPY 63.544%
Nippon Chemiphar Co., Ltd. -494 Million JPY 244.939%
Tsumura & Co. 20.01 Billion JPY 96.423%
Kissei Pharmaceutical Co., Ltd. 4.01 Billion JPY 82.176%
Torii Pharmaceutical Co., Ltd. 5.03 Billion JPY 85.782%
Towa Pharmaceutical Co., Ltd. 17.64 Billion JPY 95.943%
Fuji Pharma Co., Ltd. 3.85 Billion JPY 81.441%
Zeria Pharmaceutical Co., Ltd. 9.71 Billion JPY 92.631%
KYORIN Holdings, Inc. 6.01 Billion JPY 88.092%
Taiko Pharmaceutical Co.,Ltd. -3.07 Billion JPY 123.254%
Daito Pharmaceutical Co.,Ltd. 3.89 Billion JPY 81.613%
SymBio Pharmaceuticals Limited -811.66 Million JPY 188.213%
MedRx Co., Ltd -933 Million JPY 176.742%
Mizuho Medy Co.,Ltd. 5.15 Billion JPY 86.102%
Solasia Pharma K.K. -1.13 Billion JPY 162.862%
Modalis Therapeutics Corporation -2.37 Billion JPY 130.211%
ASKA Pharmaceutical Holdings Co.,Ltd. 6.5 Billion JPY 88.985%
Sawai Group Holdings Co., Ltd. 18.88 Billion JPY 96.209%
Cyfuse Biomedical K.K. -697.43 Million JPY 202.662%
Toho Holdings Co., Ltd. 19.33 Billion JPY 96.296%
Koa Shoji Holdings Co.,Ltd. 4.38 Billion JPY 83.662%